Recurrent vulvovaginal candidiasis.
Sobel JD.
Am J Obstet Gynecol. 2016 Jan;214(1):15-21. doi: 10.1016/j.ajog.2015.06.067. Epub 2015 Jul 9.
Global burden of recurrent vulvovaginal candidiasis: a systematic review.
Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R.
Lancet Infect Dis. 2018 Nov;18(11):e339-e347. doi: 10.1016/S1473-3099(18)30103-8. Epub 2018 Aug 2.
Recurrent vulvovaginal candidiasis.
Blostein F, Levin-Sparenberg E, Wagner J, Foxman B.
Ann Epidemiol. 2017 Sep;27(9):575-582.e3. doi: 10.1016/j.annepidem.2017.08.010. Epub 2017 Aug 15.
Recurrent vulvovaginal candidiasis.
Belayneh M, Sehn E, Korownyk C.
Can Fam Physician. 2017 Jun;63(6):455.
Recurrent vulvovaginal candidiasis.
Ringdahl EN.
Mo Med. 2006 Mar-Apr;103(2):165-8.
Recurrent vulvovaginal candidiasis: A review of guideline recommendations.
Matheson A, Mazza D.
Aust N Z J Obstet Gynaecol. 2017 Apr;57(2):139-145. doi: 10.1111/ajo.12592. Epub 2017 Mar 15.
Recurrent vulvovaginal candidiasis.
Lines A, Vardi-Flynn I, Searle C.
BMJ. 2020 Jun 8;369:m1995. doi: 10.1136/bmj.m1995.
Clinicians' Use of Intravaginal Boric Acid Maintenance Therapy for Recurrent Vulvovaginal Candidiasis and Bacterial Vaginosis.
Powell A, Ghanem KG, Rogers L, Zinalabedini A, Brotman RM, Zenilman J, Tuddenham S.
Sex Transm Dis. 2019 Dec;46(12):810-812. doi: 10.1097/OLQ.0000000000001063.
Randomised clinical trial in women with Recurrent Vulvovaginal Candidiasis: Efficacy of probiotics and lactoferrin as maintenance treatment.
Russo R, Superti F, Karadja E, De Seta F.
Mycoses. 2019 Apr;62(4):328-335. doi: 10.1111/myc.12883. Epub 2019 Feb 20.
Managing Recurrent Vulvovaginal Candidiasis.
Nagarakanti S, Grant L, Orenstein R.
J Womens Health (Larchmt). 2024 Feb;33(2):111-112. doi: 10.1089/jwh.2023.0556. Epub 2023 Oct 4.
